Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166095 | SCV000216861 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000166095 | SCV001347048 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV004562364 | SCV001673771 | likely benign | Familial adenomatous polyposis 1 | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000459466 | SCV002046096 | likely benign | not provided | 2021-03-30 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000166095 | SCV002534418 | likely benign | Hereditary cancer-predisposing syndrome | 2021-10-11 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV003995477 | SCV004843439 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004562364 | SCV005083717 | benign | Familial adenomatous polyposis 1 | 2024-04-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |